{
    "eid": "2-s2.0-85099959994",
    "title": "Solubility and stability of cediranib maleate",
    "cover-date": "2021-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Complexation",
        "Formulation",
        "Kinase inhibitor",
        "Solubility",
        "Stability"
    ],
    "authors": [
        "Pitsiree Praphanwittaya",
        "Phennapha Saokham",
        "Phatsawee Jansook",
        "Thorsteinn Loftsson"
    ],
    "citedby-count": 2,
    "ref-count": 22,
    "ref-list": [
        "Creating chemical diversity to target protein kinases",
        "Clinical pharmacokinetics of tyrosine kinase inhibitors focus on pyrimidines, pyridines and pyrroles",
        "Pharmacokinetic considerations and challenges in oral anticancer drug therapy",
        "A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, pharm res 12, 413-420, 1995-backstory of BCS",
        "Inherent formulation issues of kinase inhibitors",
        "The role of Cediranib in ovarian cancer",
        "Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study",
        "Assessment Report: Cediranib Maleate. EMA/CHMP/624101/2016",
        "Cediranib maleate-from crystal structure toward materials control",
        "Clinical pharmacokinetics and pharmacodynamics of cediranib",
        "Population pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancer",
        "Aqueous solubility of kinase inhibitors: I the effect of hydrophilic polymers on their gamma-cyclodextrin solubilization",
        "Phase-solubility techniques",
        "Self-association of cyclodextrins and cyclodextrin complexes in aqueous solutions",
        "A new approach for quantitative determination of \u03b3-cyclodextrin in aqueous solutions: application in aggregate determinations and solubility in hydrocortisone/\u03b3-cyclodextrin inclusion complex",
        "Cyclodextrins as functional excipients: methods to enhance complexation efficiency",
        "Chapter 11 - pathways of drug metabolism",
        "NMR studies of cyclodextrins and cyclodextrin complexes",
        "High-field nuclear magnetic resonance techniques for the investigation of a \u03b2-cyclodextrin:indomethacin inclusion complex",
        "Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies",
        "Characterization and photoprotection studies of a model gamma-cyclodextrin-included photolabile drug entrapped in liposomes incorporating light absorbers",
        "SciFinder"
    ],
    "affiliation": [
        {
            "affiliation-city": "Reykjavik",
            "@id": "60071113",
            "affilname": "Haskoli Islands",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071113",
            "affiliation-country": "Iceland"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60023366",
            "affilname": "Rangsit University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Icelandic center of Research",
        "UPLC/PDA/MS",
        "University of Iceland",
        "RANN\u00cdS"
    ]
}